COX-2 overexpression in different thyroid cancer histotypes has also been investigated in several studies [21,22,23], the majority of which have been aimed at evaluation of its prognostic relevance by correlating the expression levels with patients’ clinicopathological features. This evidence concerns the gene PTGS2 and thyroid cancer.